NADK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.104400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.531230E-01
Normal-vs-Stage2
1.068620E-01
Normal-vs-Stage3
1.099780E-01
Normal-vs-Stage4
4.894400E-01
Stage1-vs-Stage2
4.009600E-01
Stage1-vs-Stage3
3.875800E-01
Stage1-vs-Stage4
2.851000E-01
Stage2-vs-Stage3
9.574000E-02
Stage2-vs-Stage4
5.953000E-01
Stage3-vs-Stage4
9.076100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.960100E-02
Normal-vs-AfricanAmerican
1.557160E-01
Normal-vs-Asian
8.977400E-01
Caucasian-vs-AfricanAmerican
8.439400E-01
Caucasian-vs-Asian
1.759610E-01
AfricanAmerican-vs-Asian
1.735780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.027900E-02
Normal-vs-Female
1.213390E-01
Male-vs-Female
4.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.852000E-01
Normal-vs-Age(41-60Yrs)
9.076500E-02
Normal-vs-Age(61-80Yrs)
8.664000E-02
Normal-vs-Age(81-100Yrs)
3.819200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.575600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.353000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.314000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.948600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.258200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.995900E-02
Normal-vs-Daily Drinker
6.621600E-02
Normal-vs-Weekly Drinker
1.751030E-01
Normal-vs-Occasional Drinker
2.727200E-01
Normal-vs-Social Drinker
3.419800E-01
Non Drinker-vs-Daily Drinker
7.511000E-01
Non Drinker-vs-Weekly Drinker
4.410400E-01
Non Drinker-vs-Occasional Drinker
3.129600E-01
Non Drinker-vs-Social Drinker
8.613000E-01
Daily Drinker-vs-Weekly Drinker
6.048200E-01
Daily Drinker-vs-Occasional Drinker
4.638400E-01
Daily Drinker-vs-Social Drinker
8.979400E-01
Weekly Drinker-vs-Occasional Drinker
8.371400E-01
Weekly Drinker-vs-Social Drinker
5.279400E-01
Occasional Drinker-vs-Social Drinker
4.129000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.143600E-01
Normal-vs-Grade 2
1.634830E-01
Normal-vs-Grade 3
6.774800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.920520E-03
Grade 1-vs-Grade 3
3.384400E-02
Grade 1-vs-Grade 4
6.143600E-01
Grade 2-vs-Grade 3
1.347440E-01
Grade 2-vs-Grade 4
1.634830E-01
Grade 3-vs-Grade 4
6.774800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.738300E-02
Normal-vs-NonDiabetic
1.091970E-01
Diabetic-vs-NonDiabetic
3.808000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.478200E-01
Normal-vs-NoPancreatitis
9.233600E-02
Pancreatitis-vs-NoPancreatitis
5.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.904300E-02
Normal-vs-N1
9.169600E-02
N0-vs-N1
2.078000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.722600E-01
Normal-vs-TP53-NonMutant
2.638200E-02
TP53-Mutant-vs-TP53-NonMutant
6.623400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
